Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02130557 |
|---|---|
| Brief Title: | A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia |
| First Submitted : | May 1, 2014 |
| First Submitted that Met QC Criteria : | May 2, 2014 |
| First Posted : | May 5, 2014 (Estimate) |
| Results First Submitted : | July 13, 2018 |
| Results First Submitted that Met QC Criteria : | October 15, 2018 |
| Results First Posted : | November 14, 2018 |
| Last Update Submitted that Met QC Criteria : | April 16, 2021 |
| Last Update Posted : | May 18, 2021 |